Curanex Pharmaceuticals Inc (CURX) Corporate Subsidiaries
Curanex Pharmaceuticals Inc (CURX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CURX
CIK: 2025942
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kreit & Chiu CPA LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerJohn Delarosa
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-04 | 2026-09-03 | 8-K | 0001493152-26-041546 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-14 | 8-K | 0001493152-26-038764 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038145 | View SEC Doc Filr Page |
| S-8 | 2026-07-21 | — | S-8 | 0001493152-26-034091 | View SEC Doc Filr Page |
| DEF 14C | 2026-06-29 | 2026-06-29 | DEF 14C | 0001493152-26-030447 | View SEC Doc Filr Page |
| PRE 14C | 2026-06-18 | 2026-06-18 | PRE 14C | 0001493152-26-029388 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001493152-26-022898 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-022892 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-05 | 8-K | 0001493152-26-021658 | View SEC Doc Filr Page |
| 8-K | 2026-04-02 | 2026-04-02 | 8-K | 0001493152-26-014815 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | 10-K | 0001493152-26-013677 | View SEC Doc Filr Page |
| 8-K | 2026-03-06 | 2026-03-01 | 8-K | 0001493152-26-009155 | View SEC Doc Filr Page |
| 8-K | 2026-01-05 | 2025-12-31 | 8-K | 0001493152-26-000358 | View SEC Doc Filr Page |
| 10-Q | 2025-11-17 | 2025-09-30 | 10-Q | 0001493152-25-023710 | View SEC Doc Filr Page |
| NT 10-Q | 2025-11-17 | 2025-09-30 | NT 10-Q | 0001493152-25-023703 | View SEC Doc Filr Page |
| 8-K | 2025-11-06 | 2025-11-05 | 8-K | 0001493152-25-021028 | View SEC Doc Filr Page |
| 8-K | 2025-09-29 | 2025-09-23 | 8-K | 0001493152-25-015986 | View SEC Doc Filr Page |
| 8-K | 2025-09-12 | 2025-09-12 | 8-K | 0001493152-25-013167 | View SEC Doc Filr Page |
| 10-Q | 2025-09-09 | 2025-06-30 | 10-Q | 0001493152-25-012880 | View SEC Doc Filr Page |
| 3 | 2025-09-02 | 2025-08-25 | 3 | 0001641172-25-026284 | View SEC Doc Filr Page |
| 3 | 2025-09-02 | 2025-08-25 | 3 | 0001641172-25-026281 | View SEC Doc Filr Page |
| 3 | 2025-09-02 | 2025-08-25 | 3 | 0001641172-25-026282 | View SEC Doc Filr Page |
| 3 | 2025-09-02 | 2025-08-25 | 3 | 0001641172-25-026287 | View SEC Doc Filr Page |
| 3 | 2025-09-02 | 2025-08-25 | 3 | 0001641172-25-026283 | View SEC Doc Filr Page |
| 3 | 2025-09-02 | 2025-08-25 | 3 | 0001641172-25-026286 | View SEC Doc Filr Page |